PCN91 COST-EFFECTIVENESS OF IMMUNOTHERAPY-BASED DRUG REGIMENS FOR THE INITIAL TREATMENT OF PATIENTS WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Abstract
Authors
H. Aggarwal S. Zhang C.E. Muehlenbein K.B. Winfree Y. Zhu T. Baker